MIF
KRYS icon

Mediolanum International Funds’s Krystal Biotech KRYS Stock Holding History

Mediolanum International Funds’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.03M Buy
+15,940
New +$4.76M 0.05% 276

Other funds holding KRYS

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
TAM
Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

Mediolanum International Funds's KRYS Position: Q2 2026 in Review

Mediolanum International Funds opened a new position in Krystal Biotech (KRYS) in Q2 2026: 15,940 shares worth $6.03M. The stake represents 0.05% of the portfolio and ranks #276 among its holdings.

83 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Mediolanum International Funds held 15,940 shares of Krystal Biotech worth $6.03M as of Q2 2026.
  • Krystal Biotech was a new Mediolanum International Funds position in Q2 2026.
  • Krystal Biotech made up 0.05% of Mediolanum International Funds's portfolio in Q2 2026, its #276 holding.
  • 83 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Mediolanum International Funds's 13F filing for Q2 2026, filed 23 Jul 2026.